✦ LIBER ✦

Ifosfamide, epirubicin and vincristine alternating with oral etoposide plus cisplatin in small cell lung cancer (SCLC). A phase II trial

✍ Scribed by Rodrígeuz, CA; Martín, G; López, Y; Cruz, JJ

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral etoposide plus clsplatin alternatin

✍ Cruz, J.J.; MartÍn, G.; RodrÍguez, C.A.; Gómez, A.; Fonseca, E.; Sánchez, P.; Ga 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 264 KB

A phase II study of cyclophosphamide / a

✍ Hara, N.; Ichinose, Y.; Kuba, M.; Ichikawa, Y.; Ninomiya, K.; Shima, K.; Yamamot 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Alternating chemotherapy with adriamycin

✍ Wolf, M.; Drings, P.; Hans, K.; Schroeder, M.; Flechtner, H.; Becker, H.; Goerg, 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A phase II trial of ifosfamide (I), etop

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A phase II trial of ifosfamide (I), etop

✍ Mahjoubi, R; Llory, J; Brugiere, O; Vannetzel, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Phase II study of daily oral etoposide p

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 266 KB